BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 35062215)

  • 1. Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection.
    Katzman C; Israely T; Melamed S; Politi B; Sittner A; Yahalom-Ronen Y; Weiss S; Abu Rass R; Zamostiano R; Bacharach E; Ehrlich M; Paran N; Nissim L
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.
    Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C
    Front Immunol; 2024; 15():1383612. PubMed ID: 38742107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2.
    Hassert M; Geerling E; Stone ET; Steffen TL; Feldman MS; Dickson AL; Class J; Richner JM; Brien JD; Pinto AK
    PLoS Pathog; 2020 Dec; 16(12):e1009163. PubMed ID: 33326500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
    Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
    Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
    Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
    J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
    Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
    mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues.
    Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Li N; Tian M; Jin N; Li X
    J Virol; 2021 Nov; 95(24):e0153721. PubMed ID: 34550769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.
    Zhang J; Huang F; Xia B; Yuan Y; Yu F; Wang G; Chen Q; Wang Q; Li Y; Li R; Song Z; Pan T; Chen J; Lu G; Zhang H
    Signal Transduct Target Ther; 2021 May; 6(1):189. PubMed ID: 33980808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
    Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini MB
    Emerg Microbes Infect; 2020 Dec; 9(1):2433-2445. PubMed ID: 33073694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.
    Rawle DJ; Le TT; Dumenil T; Yan K; Tang B; Nguyen W; Watterson D; Modhiran N; Hobson-Peters J; Bishop C; Suhrbier A
    PLoS Pathog; 2021 Jul; 17(7):e1009723. PubMed ID: 34214142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion.
    Fumagalli V; Ravà M; Marotta D; Di Lucia P; Laura C; Sala E; Grillo M; Bono E; Giustini L; Perucchini C; Mainetti M; Sessa A; Garcia-Manteiga JM; Donnici L; Manganaro L; Delbue S; Broccoli V; De Francesco R; D'Adamo P; Kuka M; Guidotti LG; Iannacone M
    Sci Immunol; 2022 Jan; 7(67):eabl9929. PubMed ID: 34812647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model.
    Seibert B; Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Geiger G; Rajao DS; Ottesen E; Perez DR
    Microbiol Spectr; 2021 Sep; 9(1):e0053621. PubMed ID: 34378965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
    Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
    Bao L; Deng W; Huang B; Gao H; Liu J; Ren L; Wei Q; Yu P; Xu Y; Qi F; Qu Y; Li F; Lv Q; Wang W; Xue J; Gong S; Liu M; Wang G; Wang S; Song Z; Zhao L; Liu P; Zhao L; Ye F; Wang H; Zhou W; Zhu N; Zhen W; Yu H; Zhang X; Guo L; Chen L; Wang C; Wang Y; Wang X; Xiao Y; Sun Q; Liu H; Zhu F; Ma C; Yan L; Yang M; Han J; Xu W; Tan W; Peng X; Jin Q; Wu G; Qin C
    Nature; 2020 Jul; 583(7818):830-833. PubMed ID: 32380511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K18-hACE2 mice develop respiratory disease resembling severe COVID-19.
    Yinda CK; Port JR; Bushmaker T; Offei Owusu I; Purushotham JN; Avanzato VA; Fischer RJ; Schulz JE; Holbrook MG; Hebner MJ; Rosenke R; Thomas T; Marzi A; Best SM; de Wit E; Shaia C; van Doremalen N; Munster VJ
    PLoS Pathog; 2021 Jan; 17(1):e1009195. PubMed ID: 33465158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
    Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
    PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.